Screener
SG&A at other companies
Other financials
Where this comes from
Reported directly by Orthofix Medical Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Orthofix Medical Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333822
| (Unaudited, U.S. Dollars, in thousands, except per share data) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net sales | $210,933 | $203,121 | $407,641 | $396,767 |
| Cost of sales | 61,226 | 63,588 | 118,388 | 135,615 |
| Gross profit | 149,707 | 139,533 | 289,253 | 261,152 |
| Sales, general, and administrative | 138,030 | 136,493 | 272,941 | 269,474 |
| Research and development | 15,944 | 15,934 | 31,264 | 35,700 |
| Acquisition-related amortization, impairment, and remeasurement (Note 11) | 3,867 | 3,109 | 7,618 | 20,854 |
| Operating loss | (8,134) | (16,003) | (22,570) | (64,876) |
| Interest expense, net | (6,085) | (3,950) | (11,749) | (8,456) |
Item 1. Financial Statements
FAQ
- What is Orthofix Medical Inc.'s SG&A?
- Orthofix Medical Inc. (OFIX) reported SG&A of $138.03M in Q2 2026.
- How has Orthofix Medical Inc.'s SG&A changed year-over-year?
- Orthofix Medical Inc.'s SG&A increased by 1.1% year-over-year, from $136.49M to $138.03M.
- What is the long-term trend for Orthofix Medical Inc.'s SG&A?
- Over 3 years (2022 to 2025), Orthofix Medical Inc.'s SG&A has grown at a 21.5% compound annual growth rate (CAGR), from $308.78M to $554.33M.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.
Ask your AI about Orthofix Medical Inc.'s sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude